Prof. Juraj Payer, MD, PhDSlovakia

• Professor of Internal Medicine • Vice-president of Slovak Society of Internal

Medicine • President of Slovak Society for Osteoporosis

and Metabolic Bone Diseases• Head of the 5th Department of Internal

Medicine, Medical Faculty of Comenius University and University Hospital

• Main expert in Endocrinology, Ministry of Health of the Slovak Republic

1 st IFCA / 5th IOA 2012Prague

26.-28.4. 2011

History and traditionIFCA is a follow-up of the successful cycle I.O.A. (International Osteoporosis Academy). The academy has been extended by gynecology this year.Since 2008 until 2011 over 500 physicians have been educated at 4 postgraduate schools.

4th IOA 2011International Osteoporosis Academy

www.ospoint.org

1 at IFCA/ 5th IOA 2012International Female Care Academy

www.ospoint.org

International Female Care Academy

Hormonal disorders

Contraception

Climacteric Syndrome

HRT Treatment of Osteoporosis

Participants

Lithuania LatviaPolandTurkeyUkraineCzech RepublicRussiaRomaniaBulgariaAustriaItalyGermanySlovakia

13 countries

150 participants

Participants 1st IOA 2008 - 70

2nd IOA 2009 - 100

3rd IOA 2010 - 120

4th IOA 2011 - 150

Live broadcastingThe postgraduate school IFCA is broadcast live online

Internet website: www.ospoint.org

Credit of the events

IFCA have been accredited by:

EACCME European Accreditation Council for Continuing Medical Education www.eaccme.eu at .The EACCME is an institution of the European Union of Medical Specialists (UEMS).

IFCA - 8 CME credits

Voting system Questions

What is the capital of the Czech Republic?

1. 2. 3.

1%7%

91%1. Berlin2. Prague3. Paris

Every doctor is a contraception specialist…

1. 2. 3.

35%

33%

32%

1. Yes2. More or less …yes3. No

Do you prescribe contraception ?

1. 2. 3.

63%

18%19%

1. Yes2. No3. Occasionally

Do you prescribe HRT ?

1. 2. 3.

57%

18%

25%

1. Yes2. No3. Occasionally

Do you discuss with your patients about osteoporosis ?

1. 2. 3.

77%

11%12%

1. Yes2. No3. Occasionally

Do you prescribe bisphosphonates?

1. 2. 3.

65%

12%

24%

1. Yes2. No3. Occasionally

27th APRIL 2012

Block I Hormonal Contraceptives in PracticesChairman: Prof. Juraj Payer, MD, PhD (SK)Michael Fanta, MD, PhD (CZ)

9:00 – 9:10 Opening ceremony Chairman, Xavier Mesrobian (Zentiva)

9:10 – 9:40 Contraceptive management in clinical practice Associate Professor Angelo Cagnacci, MD, PhD (IT)

9:40 – 10:00 Overview of the benefits and risks of oral contraceptive use Michael Fanta, MD, PhD (CZ)

10:00 – 10:20 10:20 – 10:50 Coffee break 10:50 – 11:10 Progestin with a unique cardiovascular profile Prof. Juraj Payer, MD, PhD (SK)11:10 – 11:40 Hormonal contraception and bone Prof. Miroslav Borovský, MD, PhD (SK)11:40 – 12:00 Discussion 12:00 – 13:00 Lunch

Block II Bone Health in Women: Whom to Test, Whom to Treat, and How to Treat Chairman: Prof. Juraj Payer, MD, PhD (SK)

13:00 – 13:30 Care guide for menopause Prof. Hermann PG Schneider, MD, PhD (DE)

13:30 – 14:00 Postmenopausal woman and OP – Why to treat – epidemiology, patophysiology Prof. Roman Lorenc, MD, PhD (PL)

14:00 – 14:30 Coffee break

14:30 – 15:00 Postmenopausal OP – Whom to Test, Whom to treat Prof. Heinrich Resch, MD (AT)

15:00 – 15:30 How to Treat postmenopausal osteoporosis – step by step Prof. Juraj Payer, MD, PhD (SK)

15:20 – 15:30 Discussion 28th APRIL 2012Block III Care of the Older Woman: Pearls & Pitfalls9:00 – 9:20 Perimenopause and contraception Michael Fanta, MD, PhD (CZ)9:20 – 9:50 Osteoporosis case studies I prof. Alp Cetin, MD (TR)9:50 – 10:00 Coffee break 10:00 – 10:30 Osteoporosis case studies II Olga Růžičková, MD (CZ)10:30 – 11:00 Discussion, closing remarks